Search Tag: aspirin

ICU Management

Isicem22-the-place-of-antiplatelet-agents-in-covid-19-remap-cap-trial

2022 22 Mar

Thrombotic events are common in patients hospitalised with COVID-19. Platelet activation has been implicated in the COVID-19 inflammatory response. However, the efficacy of antiplatelet therapy in critically ill patients with COVID-19 is still uncertain.  The Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia...Read more

ICU Management

Recovery-trial-use-of-aspirin-in-patients-with-covid-19

2021 14 Dec

The use of aspirin has been proposed as a treatment for COVID-19 because of its anti-thrombotic properties. Thrombosis is a key feature of COVID-19, with 5-30% of hospitalised patients having a major venous thromboembolic event and up to 3% having an arterial thromboembolic event.   The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial is...Read more

IT Management

Smartphone-app-could-improve-aspirin-use-in-preeclampsia

2021 31 Oct

Hypertension disorder in pregnancy, preeclampsia, affects about 1 in every 20 pregnancies globally and usually appears after 20 weeks of gestation. Taking low-dose aspirin can help prevent preeclampsia, but this prophylactic treatment is underused among high-risk patients. A communication gap between providers and patients is one likely cause examined...Read more

Cardiology Management

Aspirin-no-longer-effective-as-primary-prevention-for-cvd

2019 16 Dec

A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use. Researchers concluded that aspirin no longer provides a net benefit as primary prevention for cardiovascular disease and cancer. Nearly half of adults 70 years...Read more

Cardiology Management

Aspirin-in-primary-prevention

2019 01 Dec

Aspirin (acetylsalicylic acid) has the unique ability to to irreversibly acetylate serine in the active site of cyclo-oxygenase (COX), permanently blocking its action in prostaglandin synthesis. This results in analgesic, antipyretic, and anti-inflammatory effects. In the platelet, it has a more durable and sustained effect. However, while aspirin...Read more

Cardiology Management

Aspirin-efficacy-all-in-the-genes

2019 25 Jul

The benefits of low-dosages of aspirin (75-100mg daily) for the secondary prevention of cardiovascular diseases (CVDs) exceed the risk of bleeding. However, most are still unclear whether aspirin has the same effects on primary prevention.   The recent results from three trials ASPREE, ASCEND and ARRIVE each tested the effects of 100mg of aspirin...Read more

Cardiology Management

Use-of-aspirin-in-individuals-without-cardiovascular-disease

2019 24 Jan

Cardiovascular disease continues to be a leading killer in the US as well as around the globe. While the number of deaths from cardiovascular disease has reduced over the years, deaths from stroke and myocardial infarction have plateaued in the US. Since the prevalence of cardiovascular disease continues to be both a health and economic burden,...Read more

Cardiology Management

Aspree-aspirin-doesn-t-prolong-disability-free-survival-in-healthy-seniors

2018 19 Sep

Results of the Aspirin in Reducing Events in the Elderly (ASPREE) trial indicate that aspirin use in healthy elderly persons (70 years or older) did not prolong disability-free survival over a period of five years but led to a higher rate of major haemorrhage than placebo. The findings are published online in The New England Journal of Medicine. ...Read more

Cardiology Management

Lack-of-evidence-for-aspirin-in-heart-failure

2017 08 Aug

The WARCEF (Warfarin Versus Aspirin in Reduced Ejection Fraction) trial indicates that, compared to warfarin, aspirin does not increase the risk of hospitalisation for heart failure. The study findings contrast with those of two previous trials that showed an increase in such risk, notes an editorial published in JACC: Heart Failure. The randomised...Read more

Cardiology Management

Aspirin-does-little-or-nothing-for-hard-arteries

2017 12 Jun

Since decades, it is believed that aspirin reduces the risk of cardiovascular problems. However, new research from University of Florida shows that aspirin may provide little or no benefit for certain patients who have plaque buildup in their arteries. Findings are published in Clinical Cardiology. Researchers tracked the health histories of more...Read more

Cardiology Management

Aspirin-doesn-t-lower-risk-of-stroke-in-low-risk-af-patients

2017 14 May

Findings from a new study conducted by researchers at the Intermountain Medical Center Heart Institute show that long-term aspirin therapy in patients who are considered to be low risk for stroke is not as effective as previously believed. The findings were presented at Heart Rhythm 2017, the Heart Rhythm Society's 38th Annual Scientific Sessions...Read more

Cardiology Management

Statins-aspirin-reduce-heart-attack-severity

2016 20 Sep

According to new research, medications prescribed for prevention of heart attacks such as statins and aspirin can also reduce the severity of heart attacks. The research is published in PLOS ONE and findings will be presented at the 27th Great Wall International Congress of Cardiology (GW-ICC). The study was conducted with 14,790 patients hospitalised...Read more

ICU Management

Helmet-based-ventilation-had-better-results-than-facemask-for-ards-patients

2016 17 May

Results of a trial of helmet-based ventilation have shown that using a transparent air-tight helmet instead of a facemask helped critically ill patients breathe better and reduced their need for mechanical ventilation. In the trial, patients who were treated with helmet ventilation spent less time in the intensive care unit and lower mortality. The...Read more

Pharmacy Management

Inappropriate-aspirin-use-in-1-in-10-low-risk-heart-patients

2015 14 Jan

According to a new study published in the Journal of the American College of Cardiology , over 10 percent of patients in a representative sample of US cardiology clinics were inappropriately taking aspirin for the primary prevention of CVD. The study also found that the inappropriate use of aspirin in different cardiology practices varied from 0 to...Read more

ICU Management

Aspirin-use-in-surgery-does-not-reduce-kidney-infection

2014 17 Nov

According to a new study, neither aspirin nor clonidine reduce the risk of acute kidney injury when used in patients undergoing non-cardiac surgery. The study has been published in JAMA and will be presented at the American Society of Nephrology’s Annual Kidney Week meeting.   Approximately 10 percent of the 200 million adults undergoing major...Read more

Pharmacy Management

Aspirin-may-protect-against-liver-fibrosis

2014 12 Nov

According to new research, aspirin is effective against liver fibrosis, especially in people who are at risk for chronic liver disease. The drug is already well-known for its cardiovascular and anti-inflammatory benefits. Gordon Jiang, MD, a gastroenterology fellow at the Beth Israel Deaconess Medical Center in Boston, revealed this latest development...Read more